LA
IDXX icon

Legacy Advisors’s Idexx Laboratories IDXX Stock Holding History

Legacy Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,975
Closed -$829K – 194
2025
Q1 		$829K Buy
1,975
+48
+2% +$20.8K 0.09% 189
2024
Q4 		$797K Buy
1,927
+10
+0.5% +$4.39K 0.08% 193
2024
Q3 		$969K Sell
1,917
-826
-30% -$401K 0.1% 148
2024
Q2 		$1.34M Buy
2,743
+46
+2% +$23.1K 0.16% 100
2024
Q1 		$1.46M Buy
2,697
+224
+9% +$122K 0.18% 100
2023
Q4 		$1.37M Sell
2,473
-97
-4% -$45.5K 0.18% 102
2023
Q3 		$1.12M Buy
2,570
+137
+6% +$68.3K 0.18% 107
2023
Q2 		$1.22M Buy
2,433
+103
+4% +$49.4K 0.18% 99
2023
Q1 		$1.17M Buy
2,330
+57
+3% +$27.3K 0.21% 85
2022
Q4 		$927K Buy
2,273
+707
+45% +$274K 0.17% 95
2022
Q3 		$510K Buy
1,566
+384
+32% +$141K 0.11% 121
2022
Q2 		$415K Buy
1,182
+476
+67% +$194K 0.09% 137
2022
Q1 		$386K Buy
+706
New +$371K 0.08% 142

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Legacy Advisors's IDXX Position: Q2 2025 in Review

Legacy Advisors sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 1,975 shares — an estimated $829K sold.

Legacy Advisors first reported a position in IDXX in Q1 2022 and held it in 13 quarters. The position peaked at $1.46M in Q1 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Legacy Advisors reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Legacy Advisors sold 1,975 Idexx Laboratories shares in Q2 2025, an estimated $829K.
  • Legacy Advisors first reported a position in Idexx Laboratories in Q1 2022 and held it in 13 quarters.
  • Legacy Advisors's Idexx Laboratories position peaked at $1.46M in Q1 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Legacy Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.